Background and objectives Krebs von den Lungen-6 (KL-6), expressed by damaged type II
pneumocytes, is useful in the diagnosis and severity assessment of many diffuse interstitial …

The clinical relevance of Krebs von den Lungen-6 (KL-6) levels in patients with coronavirus
disease 2019 (COVID-19) is unclear. This study aimed to evaluate the correlation between …

Abstract Background Serum Krebs von den Lungen 6 (KL-6), which reflects alveolar
epithelial injury, was reported to be useful to predict the progression of pneumonitis induced …

The SARS-CoV-2 (COVID-19) pandemic is a major issue that necessitates the use of cutting-
edge disease prediction models. The aim of the study was to assess the existing evidence …

Abstract Background Coronavirus disease 2019 (COVID-19) is currently spreading
worldwide. This study examined whether serum Krebs von den Lungen-6 (KL-6) level is a …

To investigate the dynamic changes of Krebs von den Lungen‐6 (KL‐6) among patients with
coronavirus disease 2019 (COVID‐19) and the role of KL‐6 as a noninvasive biomarker for …

Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial
lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Background Coronavirus disease COVID-19 has become a public health emergency of
international concern. Together with the quest for an effective treatment, the question of the …

Abstract Background The serum Krebs von den Lungen-6 (KL-6) level is a predictive factor
for acute respiratory distress syndrome (ARDS). The development of ARDS has been …

Krebs von den Lungen-6 (KL-6) is a glycoprotein mainly expressed by type II pneumocytes
and recently known as a lung injury biomarker. However, the number of studies is still …